One of the primary challenges in studying the FUS-DDIT3 fusion gene is the rarity of myxoid liposarcoma, which limits the availability of clinical samples. Additionally, the complexity of the fusion gene and its downstream effects on cellular signaling pathways present challenges in understanding its full biological impact. Advances in molecular biology and histological techniques are essential to overcome these challenges.
